Surgical Role for Metastatic Disease/Modern Controversies
With decades of experience, we have developed solutions that support your skin health
doi: 10.1038/s44324-024-00033-2 Summary Keywords hypothyroidism, MAFLD, ECM remodeling, HSC, TH signaling, liver fibrosis Citation Wang T, Duan L, Zhao B, Zhang J, Yu Y and Zhao J (2025) ECM remodeling in hypothyroidism-associated MAFLD: mechanisms, clinical relevance, and therapeutic targets
Prescription products require an online evaluation with a licensed medical professional who will determine if treatment is appropriate
The FDA approved oral semaglutide 25 mg (Wegovy tablet) on December 22, 2025, based on the phase 3 OASIS 4 clinical trial
"Gastrointestinal side effects can still occur, and more severe, dose-independent risks like pancreatitis remain a possibility